Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-08-03
2000-08-01
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514378, 514563, 548236, 548248, 560104, 562495, A01N 4376, A01N 4380, A61K 3142, A61K 31195
Patent
active
060967706
ABSTRACT:
Compounds of the formula: ##STR1## wherein: R.sub.1, R.sub.2 and R.sub.3 are, independently, hydrogen, nitro, cyano, C.sub.1-10 haloalkoxy, amino, C.sub.1-10 alkylamino, sulfo, sulfamoyl, C.sub.1-10 alkylsulfonamido, C.sub.2-10 alkylcarboxamido C.sub.2-10 alkanoyl, C.sub.1-10 alkylsulfonyl, C.sub.1-10 haloalkylsulfonyl, C.sub.1-10 carboxyl, C.sub.1-10 haloalkyl and C.sub.6-12 aryl; with the provisos: (1) that R.sub.1, R.sub.2 and R.sub.3 may not all simultaneously be hydrogen, and (2) when R.sub.1 and R.sub.2 are hydrogen, R.sub.3 may not be meta-CF.sub.3 ;
REFERENCES:
Derwent Abst. J5 9070654 (Lederle Japan Ltd.) (1984).
Antane Schuyler Adam
Butera John Anthony
Lennox Joseph Richard
American Home Products Corporation
Barrett Rebecca R.
Davis Brian J.
Richter Johann
LandOfFree
Anthranilic acid analogs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anthranilic acid analogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anthranilic acid analogs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-664431